Drug case

As veterinary medicines is subject to regulatory restrictions that apply to the entire pharmaceutical industry Virbac. This is equally important or even more important for some of the technical aspects, such as those for human medicine (ecotoxicology, and tissue residues).

Virbac Pharmaceutical Company veterinary subject to regulatory restrictions which apply to the entire industry pharmaceutiqueEn Europe and the United States and Japan, but also in most industrialized countries require regulations different that have been registered veterinary medicines with national authorities or community, thus ensuring the quality and safety and to ensure the effectiveness of the products in the market. This requires a perfect mastery of the technical development of each specialty and in-depth knowledge of how to record more or less specific to each country or group of countries.

AN ongoing monitoring

During the economic life in the specialty of veterinary medicine, any slight change in the (process and production facility, and the quality of the ingredients improves, and the observed side effects ...) must be reported to the competent authorities. Technical control of veterinary drugs is durable, so that compliance with the regulations that arise in response to the input of a new technology, but also by changes in the behavior of civil society (for example, to ensure, as appropriate, ecotoxicology in the use of specialty). Does not freeze the regulatory status of the property.

These restrictions set by Europe and the United States, Japan and some other developed countries is scheduled to be gradual in most countries with legislation in the field of veterinary medicine (Brazil, China, India ...) transferred. Virbac, about 4500 in more than 100 countries available records managed by the Ministry of Affairs of Reglementaireset medicines and regional correspondents. Each year also be performed nearly 3,000 regulatory procedures to obtain and maintain Virbac at headquarters.